Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Creating a life-saving killer

16.08.2010
Cancer may be kept in check by a method for generating patient-specific immune cells with antitumor activity

Upon receiving the appropriate activating signal, natural killer T (NKT) cells live up to their name, releasing a torrent of molecules that trigger the protective immune response necessary to eliminate pathogens or even thwart tumor growth.

These cells represent a promising clinical tool, as demonstrated in a recent clinical trial in which lung cancer patients received NKT-stimulating injections of dendritic cells that had been pretreated with á-galactosylceramide (á-GalCer)1. Some 60% of treated patients exhibited a striking seven-fold improvement in their median survival time relative to their untreated counterparts. “The effects are superior to other molecular-targeted cancer drugs,” says Masaru Taniguchi of the RIKEN Research Center for Allergy and Immunology (RCAI), Yokohama, whose team participated in this study. “However, this therapy is not applicable to two-thirds of patients because of their limited number of NKT cells.”

To solve this problem, Taniguchi teamed up with RCAI colleague Haruhiko Koseki to develop a method for generating transplantable NKTs2. They derived these from induced pluripotent stem cells (iPSCs), embryonic-like cells that are typically generated via virus-mediated delivery of ‘reprogramming genes’ into skin cells. However, NKT maturation involves a complex genomic rearrangement event, making them difficult to derive from conventional iPSCs. As such, Taniguchi and Koseki devised a novel approach for generating mouse iPSCs from existing NKTs, which have already undergone this rearrangement. They used these iPSCs to generate large numbers of new NKTs in vitro.

Their method efficiently produced mature NKTs, which rapidly established a stable population within the liver upon transplantation into mice. To the researchers’ pleasant surprise, these new NKTs displayed typical activation behavior in response to á-GalCer-treated dendritic cells and proved capable of coordinating an effective immune response. “In general, cells generated from in vitro culture die quickly in vivo or are killed by host immune cells … however, this was not the case here,” says Taniguchi. “We detected iPSC-derived NKT cells with adjuvant activity and tumor-eradicating effects two weeks after cell transfer.”

Taniguchi, Koseki and colleagues are now keen to begin working with human cells. This transition will involve many new challenges, but the researchers see great clinical potential in their approach—particularly in the US, where the Food and Drug Administration has approved development of cell-based therapies. “NKT cell-targeted adjuvant cell therapy is applicable [to] any type of cancer patient, because it can overcome [their] immunodeficient status and enhances antitumor responses,” says Taniguchi. “At present, the delivery of patient dendritic cells is the main limiting factor.”

The corresponding author for this highlight is based at the Laboratory for Immune Regulation, RIKEN Research Center for Allergy and Immunology

Associated links

Link to article
Journal information
1. 1.Motohashi, S., Nagato, K., Kunii, N., Yamamoto, H., Yamasaki, K., Okita, K., Hanaoka, H., Shimizu, N., Suzuki, M., Yoshino, I., et al. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. Journal of Immunology 182, 2492–2501 (2009).

2. 2.Watarai, H., Fujii, S., Yamada, D., Rybouchkin, A., Sakata, S., Nagata, Y., Iida-Kobayashi, M., Sekine-Kondo, E., Shimizu, K., Shozaki, Y. et al. Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells. The Journal of Clinical Investigation 120, 2610–2618 (2010).

gro-pr | Research asia research news
Further information:
http://www.riken.jp
http://www.researchsea.com

More articles from Life Sciences:

nachricht Repairing damaged hearts with self-healing heart cells
22.08.2017 | National University Health System

nachricht Biochemical 'fingerprints' reveal diabetes progression
22.08.2017 | Umea University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>